Far East Financials: Two Large Chinese Device Firms Report Mixed Growth
This article was originally published in The Gray Sheet
Executive Summary
China Medical's molecular diagnostic system sales were up 10% in the first quarter to $15.9 million, driven by progress with its fluorescent in situ hybridization probe business, the Beijing company reported Aug. 16
You may also be interested in...
China Medical Technologies Invests $345 Million In HPV Genotyping Chip
China Medical Technologies is acquiring a human papillomavirus genotyping assay which it expects will generate up to $26.5 million in sales next year
J&J And Sanofi Team Up On Phase III E. Coli Vaccine
Sanofi will pay $175m up front for rights to commercialize J&J’s potential first-in-class vaccine against E. coli. The two companies will share profits.
Minute Insight: Medtronic May Sell Respiratory And Monitoring Units To Private Equity
Reuters reported that global private equity firm Carlyle Group has offered to pay at least $7bn for Medtronic’s patient monitoring and respiratory interventions businesses. Medtronic announced its plan to get out of those businesses about one year ago.